BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. (Q50983488)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Su-jin Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kyu Eun Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jeong-hwan Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yoon Kyung Jeon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Hye Sook Min

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

So Yeon Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kyeong Cheon Jung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Do Hoon Koo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Yeo-Kyu Youn

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

published in

World Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

310-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00268-011-1383-1

19 January 2020

exact match

0 references

cites work

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Guilty as charged: B-RAF is a human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Natural history, treatment, and course of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF mutations in an Italian cohort of thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

BRAF(V600E) mutation and the biology of papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Papillary carcinoma of the thyroid <or=1.0 cm: rarely incidental or occult any more

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-1383-1

Raf proteins and cancer: B-Raf is identified as a mutational target

21 January 2018

1 reference

12 December 2020

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta-analysis

1 reference

12 December 2020

BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas

1 reference

12 December 2020

Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).

1 reference

12 December 2020

Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients

1 reference

12 December 2020

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

1 reference

12 December 2020

Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma

1 reference

12 December 2020

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 reference

12 December 2020

Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings

1 reference

12 December 2020

BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases

1 reference

12 December 2020

10.1007/S00268-011-1383-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22190222%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference